News
TWST
92.53
+2.41%
2.18
Canaccord Genuity Maintains Buy on Twist Bioscience, Raises Price Target to $120
Benzinga · 20h ago
Twist Bioscience price target raised to $120 from $90 at Canaccord
TipRanks · 21h ago
Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku
Seeking Alpha · 1d ago
Weekly Report: what happened at TWST last week (0706-0710)?
Weekly Report · 1d ago
Is Twist Bioscience’s (TWST) AI Order Momentum Reshaping Its Core Life Sciences Investment Story?
Simply Wall St · 3d ago
Noteworthy ETF Outflows: XBI, APGE, KYMR, TWST
NASDAQ · 4d ago
Twist Bioscience: An AI And Rate Cut Play Dressed In A Lab Coat
Seeking Alpha · 6d ago
AMD Stock: Cathie Wood Sells $8M in AMD Despite Growing Analyst Optimism
TipRanks · 07/07 12:29
Tesla, AMD, and SpaceX headline Cathie Wood's biggest H1 portfolio bets
Seeking Alpha · 07/06 16:15
Twist Bioscience Price Target Raised to $102.00/Share From $66.00 by Evercore ISI Group
Dow Jones · 07/06 12:38
Twist Bioscience Cut to In-Line From Outperform by Evercore ISI Group
Dow Jones · 07/06 12:38
Evercore ISI Group Downgrades Twist Bioscience to In-Line, Raises Price Target to $102
Benzinga · 07/06 12:27
Twist Bioscience downgraded to In Line from Outperform at Evercore ISI
TipRanks · 07/06 12:06
Cathie Wood's weekly recap: builds Tesla, crypto positions; pares Roku, China tech
Seeking Alpha · 07/06 11:05
Weekly Report: what happened at TWST last week (0629-0703)?
Weekly Report · 07/06 10:16
TWIST BIOSCIENCE CORP <TWST.O>: EVERCORE ISI CUTS TO IN LINE FROM OUTPERFORM; RAISES TARGET PRICE TO $102 FROM $66
Reuters · 07/06 10:11
Coda Octopus appoints Mark Kelly CFO effective Aug. 3, 2026
PUBT · 07/06 10:11
U.S. RESEARCH ROUNDUP-East West Bancorp, First Citizens Bancshares, UMB Financial
Reuters · 07/06 08:21
Cathie Wood Loads Up on Tesla and SoFi Ahead of Holiday Break, Trims Roku and Biotech Stocks
TipRanks · 07/03 10:08
More
Webull provides a variety of real-time TWST stock news. You can receive the latest news about Twist Bioscience through multiple platforms. This information may help you make smarter investment decisions.
About TWST
Twist Bioscience Corporation provides customizable solutions across the biological continuum that enable scientific discovery and development across therapeutics, diagnostics, and other high-growth markets. The Company's proprietary silicon-based platform delivers precision, scale, and speed, supporting consistent, high-quality performance across a range of applications. The Company’s platform is a differentiated method of manufacturing synthetic deoxyribonucleic acid (DNA) by writing DNA on a silicon chip. By integrating proprietary hardware, software, and scalable infrastructure, including its e-commerce platform. The Company has extended this platform beyond DNA synthesis to offer an integrated portfolio that includes synthetic genes, next-generation sequencing, applications, sample preparation tools, antibody libraries, and biologic discovery services. Leveraging the same platform, it also manufactures synthetic ribonucleic acid (RNA) and expresses antibody proteins.